Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adma Biologics (NQ: ADMA )

3.850 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 23
Open 3.850
Bid (Size) 3.810 (3)
Ask (Size) 3.970 (3)
Prev. Close 3.850
Today's Range 3.850 - 3.850
52wk Range 2.945 - 4.650
Shares Outstanding 196,357,149
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Adma Biologics Stock Crushed the Market on Friday
The network of FDA-approved collection facilities continues to grow. 
Via The Motley Fool
ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
FDA Approval Signifies the Accomplishment of ADMA’s Corporate Goal of Plasma Supply Self-Sufficiency 
From ADMA Biologics, Inc.
Via GlobeNewswire

Performance

YTD
-0.52%
-0.52%
1 Month
+16.67%
+16.67%
3 Month
+1.58%
+1.58%
6 Month
-3.51%
-3.51%
1 Year
+18.83%
+18.83%

More News

Read More
Why Adma Biologics Was Trouncing the Market Today
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Earnings Preview: ADMA Biologics
Via Benzinga
Preview: ADMA Biologics's Earnings
Via Benzinga
Recap: ADMA Biologics Q1 Earnings
Via Benzinga
A Preview Of ADMA Biologics's Earnings
Via Benzinga
ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Why Shares of ADMA Biologics Are Climbing Thursday
Via The Motley Fool
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces Amendment to Credit Agreement
From ADMA Biologics, Inc.
Via GlobeNewswire
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
ADMA Biologics, C3.ai And Other Big Stocks Moving Higher On Friday
Via Benzinga
Dow Down 150 Points; US Durable Goods Orders Drop In February
Via Benzinga
Oxford Industries, Express And 3 Stocks To Watch Heading Into Friday
Via Benzinga
After-Hours Action: Why ADMA Biologics Shares Are Trading Higher
Via Benzinga
ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Earnings Scheduled For March 23, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.